WHO ICTRP trial
Study on the pathogenesis of abnormal ß-alanine metabolism in dysthyroid optic…
ChiCTR2300067995 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300067995 |
|---|---|
| Public title | Study on the pathogenesis of abnormal ß-alanine metabolism in dysthyroid optic neuropathy |
| Scientific title | Study on the pathogenesis of abnormal ß-alanine metabolism in dysthyroid optic neuropathy |
| Primary sponsor | Eye Hospital Affiliated to Wenzhou Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Dysthyroid optic neuropathy |
| Interventions | experimental group:taurine;control group:placebo;healthy control group:none |
| Registration date | Feb 2, 2023 |
| Target size | experimental group:30;control group:30;healthy control group:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: